Systemic inflammation-related sinus bradycardia in COVID-19 infection has not been well described yet. This six-patient case series excludes common causes of bradycardia. As bradycardia may be a sequela of COVID-19 infection, we recommend closely monitoring hemodynamics and stopping medications that can exacerbate bradycardia in these patients.
CITATION STYLE
Srinivasan, A., Pansuriya, T., Wilson, B., Sarva, S. T., Jayaram, T., Alim, S., … Raza, S. (2021). Systemic Inflammation-Related Bradycardia in COVID-19. Case Reports in Cardiology, 2021, 1–6. https://doi.org/10.1155/2021/9986955
Mendeley helps you to discover research relevant for your work.